186 related articles for article (PubMed ID: 34142831)
1. Disproportionation of Pharmaceutical Salts: pH
Avdeef A
Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
[TBL] [Abstract][Full Text] [Related]
2. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH
Avdeef A; Sugano K
J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Barriers to Disproportionation of Salts of Weakly Basic Drugs.
Van Duong T; Diab S; Hodnett NS; Taylor LS
Mol Pharm; 2023 Aug; 20(8):3886-3894. PubMed ID: 37494545
[TBL] [Abstract][Full Text] [Related]
4. Stability of pharmaceutical salts in solid oral dosage forms.
Nie H; Byrn SR; Zhou QT
Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
[TBL] [Abstract][Full Text] [Related]
5. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
[TBL] [Abstract][Full Text] [Related]
6. Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.
Hsieh YL; Merritt JM; Yu W; Taylor LS
Pharm Res; 2015 Sep; 32(9):3110-8. PubMed ID: 25874534
[TBL] [Abstract][Full Text] [Related]
7. Salt disproportionation: A material science perspective.
Thakral NK; Kelly RC
Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
[TBL] [Abstract][Full Text] [Related]
8. Quantifying Disproportionation in Pharmaceutical Formulations with
Hirsh DA; Su Y; Nie H; Xu W; Stueber D; Variankaval N; Schurko RW
Mol Pharm; 2018 Sep; 15(9):4038-4048. PubMed ID: 30016112
[TBL] [Abstract][Full Text] [Related]
9. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging.
Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW
Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
[TBL] [Abstract][Full Text] [Related]
11. Impact of Solid-State Form on the Disproportionation of Miconazole Mesylate.
Patel MA; Luthra S; Shamblin SL; Arora K; Krzyzaniak JF; Taylor LS
Mol Pharm; 2018 Jan; 15(1):40-52. PubMed ID: 29202237
[TBL] [Abstract][Full Text] [Related]
12. Role of salt and excipient properties on disproportionation in the solid-state.
Guerrieri P; Taylor LS
Pharm Res; 2009 Aug; 26(8):2015-26. PubMed ID: 19507008
[TBL] [Abstract][Full Text] [Related]
13. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.
John CT; Xu W; Lupton LK; Harmon PA
Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680
[TBL] [Abstract][Full Text] [Related]
14. Impact of mixed counter ion on saturation solubility of esylate salt of a weak basic drug to formulate physically stable and non-hemolytic ready to use injectable solution.
Dalwadi G; Sun Y; Wang L; Shick J; Hicks K; Lam S; Tuliani V; Patel K
Int J Pharm; 2019 Dec; 572():118829. PubMed ID: 31715348
[TBL] [Abstract][Full Text] [Related]
15. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
Patel MA; Luthra S; Shamblin SL; Arora KK; Krzyzaniak JF; Taylor LS
Int J Pharm; 2018 Jul; 546(1-2):226-234. PubMed ID: 29772284
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
Koranne S; Lalge R; Suryanarayanan R
Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293
[TBL] [Abstract][Full Text] [Related]
17. Crystalline solid dispersion-a strategy to slowdown salt disproportionation in solid state formulations during storage and wet granulation.
Nie H; Xu W; Taylor LS; Marsac PJ; Byrn SR
Int J Pharm; 2017 Jan; 517(1-2):203-215. PubMed ID: 27979765
[TBL] [Abstract][Full Text] [Related]
18. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
[TBL] [Abstract][Full Text] [Related]
19. Nortriptyline Hydrochloride Solubility-pH Profiles in a Saline Phosphate Buffer: Drug-Phosphate Complexes and Multiple pH
Marković OS; Patel NG; Serajuddin ATM; Avdeef A; Verbić TŽ
Mol Pharm; 2022 Feb; 19(2):710-719. PubMed ID: 35050628
[TBL] [Abstract][Full Text] [Related]
20. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
